
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Adenosine Metabolism: Emerging Concepts for Cancer Therapy
Detlev Boison, Gennady G. Yegutkin
Cancer Cell (2019) Vol. 36, Iss. 6, pp. 582-596
Open Access | Times Cited: 260
Detlev Boison, Gennady G. Yegutkin
Cancer Cell (2019) Vol. 36, Iss. 6, pp. 582-596
Open Access | Times Cited: 260
Showing 1-25 of 260 citing articles:
The adenosine pathway in immuno-oncology
Bertrand Allard, David Allard, Laurence Buisseret, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 611-629
Closed Access | Times Cited: 398
Bertrand Allard, David Allard, Laurence Buisseret, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 611-629
Closed Access | Times Cited: 398
Targeting CD39 in cancer
Achim K. Moesta, Xian-Yang Li, Mark J. Smyth
Nature reviews. Immunology (2020) Vol. 20, Iss. 12, pp. 739-755
Closed Access | Times Cited: 251
Achim K. Moesta, Xian-Yang Li, Mark J. Smyth
Nature reviews. Immunology (2020) Vol. 20, Iss. 12, pp. 739-755
Closed Access | Times Cited: 251
Inosine is an alternative carbon source for CD8+-T-cell function under glucose restriction
Tingting Wang, JN Rashida Gnanaprakasam, Xuyong Chen, et al.
Nature Metabolism (2020) Vol. 2, Iss. 7, pp. 635-647
Open Access | Times Cited: 226
Tingting Wang, JN Rashida Gnanaprakasam, Xuyong Chen, et al.
Nature Metabolism (2020) Vol. 2, Iss. 7, pp. 635-647
Open Access | Times Cited: 226
Extracellular ATP: A Feasible Target for Cancer Therapy
Valentina Vultaggio-Poma, Alba Clara Sarti, Francesco Di Virgilio
Cells (2020) Vol. 9, Iss. 11, pp. 2496-2496
Open Access | Times Cited: 188
Valentina Vultaggio-Poma, Alba Clara Sarti, Francesco Di Virgilio
Cells (2020) Vol. 9, Iss. 11, pp. 2496-2496
Open Access | Times Cited: 188
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
Yuchen Wang, Hao Zhang, Chao Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 172
Yuchen Wang, Hao Zhang, Chao Liu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 172
Hypoxia drives CD39-dependent suppressor function in exhausted T cells to limit antitumor immunity
Paolo Vignali, Kristin DePeaux, McLane J. Watson, et al.
Nature Immunology (2022) Vol. 24, Iss. 2, pp. 267-279
Open Access | Times Cited: 156
Paolo Vignali, Kristin DePeaux, McLane J. Watson, et al.
Nature Immunology (2022) Vol. 24, Iss. 2, pp. 267-279
Open Access | Times Cited: 156
The metabolic basis of epilepsy
Jong M. Rho, Detlev Boison
Nature Reviews Neurology (2022) Vol. 18, Iss. 6, pp. 333-347
Closed Access | Times Cited: 149
Jong M. Rho, Detlev Boison
Nature Reviews Neurology (2022) Vol. 18, Iss. 6, pp. 333-347
Closed Access | Times Cited: 149
CD39/CD73/A2AR pathway and cancer immunotherapy
Chenglai Xia, Shuanghong Yin, Kenneth K.W. To, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 143
Chenglai Xia, Shuanghong Yin, Kenneth K.W. To, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 143
Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy
Huailiang Wu, Yue Gong, Peng Ji, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 110
Huailiang Wu, Yue Gong, Peng Ji, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 110
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
Adriaan P. IJzerman, Kenneth A. Jacobson, Christa E. Müller, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 2, pp. 340-372
Open Access | Times Cited: 109
Adriaan P. IJzerman, Kenneth A. Jacobson, Christa E. Müller, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 2, pp. 340-372
Open Access | Times Cited: 109
Astrocytes in the initiation and progression of epilepsy
Annamaria Vezzani, Teresa Ravizza, Peter Bedner, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 12, pp. 707-722
Open Access | Times Cited: 104
Annamaria Vezzani, Teresa Ravizza, Peter Bedner, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 12, pp. 707-722
Open Access | Times Cited: 104
Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 101
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 101
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain
Gennady G. Yegutkin, Detlev Boison
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 799-824
Open Access | Times Cited: 91
Gennady G. Yegutkin, Detlev Boison
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 799-824
Open Access | Times Cited: 91
The expanding role for small molecules in immuno-oncology
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 86
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 86
Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy
Reza Hosseini, Hamzeh Sarvnaz, Maedeh Arabpour, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 75
Reza Hosseini, Hamzeh Sarvnaz, Maedeh Arabpour, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 75
Effect of Extracellular Vesicles Derived From Tumor Cells on Immune Evasion
Xixi Liu, Kenneth K.W. To, Qinsong Zeng, et al.
Advanced Science (2025)
Open Access | Times Cited: 2
Xixi Liu, Kenneth K.W. To, Qinsong Zeng, et al.
Advanced Science (2025)
Open Access | Times Cited: 2
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease
Karen M. Dwyer, Bellamkonda Kishore, Simon C. Robson
Nature Reviews Nephrology (2020) Vol. 16, Iss. 9, pp. 509-524
Closed Access | Times Cited: 102
Karen M. Dwyer, Bellamkonda Kishore, Simon C. Robson
Nature Reviews Nephrology (2020) Vol. 16, Iss. 9, pp. 509-524
Closed Access | Times Cited: 102
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
Harry Ho Man Ng, Ren Yuan Lee, Siting Goh, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000987-e000987
Open Access | Times Cited: 101
Harry Ho Man Ng, Ren Yuan Lee, Siting Goh, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e000987-e000987
Open Access | Times Cited: 101
Interactions between gastric microbiota and metabolites in gastric cancer
Daofeng Dai, Yan Yang, Jieqing Yu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 12
Open Access | Times Cited: 90
Daofeng Dai, Yan Yang, Jieqing Yu, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 12
Open Access | Times Cited: 90
CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
Jerry B. Harvey, Luan Phan, Oscar E. Villarreal, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 72
Jerry B. Harvey, Luan Phan, Oscar E. Villarreal, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 72
ATP and adenosine—Two players in the control of seizures and epilepsy development
Edward Beamer, Manvitha Kuchukulla, Detlev Boison, et al.
Progress in Neurobiology (2021) Vol. 204, pp. 102105-102105
Open Access | Times Cited: 72
Edward Beamer, Manvitha Kuchukulla, Detlev Boison, et al.
Progress in Neurobiology (2021) Vol. 204, pp. 102105-102105
Open Access | Times Cited: 72
Cancer-associated adipocytes as immunomodulators in cancer
Qi Wu, Bei Li, Juanjuan Li, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 69
Qi Wu, Bei Li, Juanjuan Li, et al.
Biomarker Research (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 69
Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer
Г. А. Жулай, Е. К. Олейник, Mikhail A. Shibaev, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 418-418
Open Access | Times Cited: 63
Г. А. Жулай, Е. К. Олейник, Mikhail A. Shibaev, et al.
Biomolecules (2022) Vol. 12, Iss. 3, pp. 418-418
Open Access | Times Cited: 63
CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
Nataliia Petruk, Sanni Tuominen, Malin Åkerfelt, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 57
Nataliia Petruk, Sanni Tuominen, Malin Åkerfelt, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 57
Single cell sequencing reveals that CD39 inhibition mediates changes to the tumor microenvironment
Lilong Liu, Yaxin Hou, Changqi Deng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
Lilong Liu, Yaxin Hou, Changqi Deng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43